bevacizumab
Avastin (Off-Label Anti-VEGF)
Plain-language definition
An anti-VEGF antibody originally for cancer, widely used off-label as a lower-cost eye injection for wet AMD, DME, and vein occlusions.
Where this term comes up
“Bevacizumab (Avastin): off-label but widely used”
Treatment · Intravitreal Injection
“Bevacizumab (Avastin) studied”
Condition · Radiation-Induced Optic Neuropathy
“Bevacizumab (Avastin): off-label but widely used”
Condition · Wet Age-Related Macular Degeneration (Wet AMD)
- Category
- Medication
- Also written as
- No alternate forms listed.
Medication terms describe drugs or drug classes that may be used in eye care, neurology, inflammation, infection, or pain treatment.
Related glossary terms
- anti-VEGF
Anti-Vascular Endothelial Growth Factor
- ranibizumab
Lucentis (Anti-VEGF)
- macula
Central Retina
- aflibercept
Eylea (Anti-VEGF)
- hemorrhage
Bleeding
- fundus
Back of the Eye
A note on medical context
A glossary definition can explain a word, but it cannot tell you whether a symptom or test result is serious. If this term came from an article, use the full article and your clinician's guidance for context.